BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11237526)

  • 1. Mouse models for sporadic cancer.
    Meuwissen R; Jonkers J; Berns A
    Exp Cell Res; 2001 Mar; 264(1):100-10. PubMed ID: 11237526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional mouse models of sporadic cancer.
    Jonkers J; Berns A
    Nat Rev Cancer; 2002 Apr; 2(4):251-65. PubMed ID: 12001987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
    Zanesi N; Pekarsky Y; Croce CM
    Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63: oncogene or tumor suppressor?
    Mills AA
    Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of tumor immunity, immunotherapy and cancer vaccines.
    Ostrand-Rosenberg S
    Curr Opin Immunol; 2004 Apr; 16(2):143-50. PubMed ID: 15023405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional mouse models of cancer.
    Vignjevic D; Fre S; Louvard D; Robine S
    Handb Exp Pharmacol; 2007; (178):263-87. PubMed ID: 17203659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling cancer in mice.
    Jackson-Grusby L
    Oncogene; 2002 Aug; 21(35):5504-14. PubMed ID: 12154411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models for human head and neck squamous cell carcinomas.
    Lu SL; Herrington H; Wang XJ
    Head Neck; 2006 Oct; 28(10):945-54. PubMed ID: 16721744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer gene therapy: strategies and clinical trials.
    Prados J; Melguizo C; Boulaiz H; Marchal JA; Aránega A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):23-36. PubMed ID: 16171562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches for modelling cancer mechanisms in the mouse.
    Maddison K; Clarke AR
    J Pathol; 2005 Jan; 205(2):181-93. PubMed ID: 15641017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene addiction: sometimes a temporary slavery.
    Jonkers J; Berns A
    Cancer Cell; 2004 Dec; 6(6):535-8. PubMed ID: 15607957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer.
    Murakami Y
    Oncogene; 2002 Oct; 21(45):6936-48. PubMed ID: 12362275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
    Jonkers J; Meuwissen R; van der Gulden H; Peterse H; van der Valk M; Berns A
    Nat Genet; 2001 Dec; 29(4):418-25. PubMed ID: 11694875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mouse models for the prevention of breast cancer.
    Shen Q; Brown PH
    Mutat Res; 2005 Aug; 576(1-2):93-110. PubMed ID: 15888345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling disease in the mouse: lessons from DNA damage response and cell cycle control genes.
    Adelman CA; Petrini JH; Attwooll CL
    J Cell Biochem; 2006 Feb; 97(3):459-73. PubMed ID: 16288461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application and recent advances of laboratory mouse in human cancer research].
    Liu EQ; Kitajima S; Morimoto M
    Ai Zheng; 2005 Feb; 24(2):249-54. PubMed ID: 15694046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
    Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
    Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Designer' tumors in mice.
    Politi K; Kljuic A; Szabolcs M; Fisher P; Ludwig T; Efstratiadis A
    Oncogene; 2004 Feb; 23(8):1558-65. PubMed ID: 14661057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.